Day One Biopharmaceuticals (DAWN) PT Lowered to $17 at Needham
Tweet Send to a Friend
Needham analyst Ami Fadia lowered the price target on Day One Biopharmaceuticals (NASDAQ: DAWN) to $17.00 (from $18.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
